Skip to main content
TipRanks
Go Ultimate75% OFF

Tvardi Therapeutics (TVRD) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

TVRD Analyst Ratings

Moderate Buy
7Ratings
5Buy1Hold1Sell
Based on 7 analysts giving stock ratings to Tvardi Therapeutics in the past 3 months

TVRD Stock 12 Month Forecast

CHF6.74▲(0.00% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Tvardi Therapeutics in the last 3 months. The average price target is CHF 6.74 with a high forecast of CHF 11.56 and a low forecast of CHF 2.48. The average price target represents a ― change from the last price of ―.
Highest Price TargetCHF11.56Average Price TargetCHF6.74Lowest Price TargetCHF2.48

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:TVRD
Price TargetArticle
JonesTradingCHF8.25buy―Reiterated11/08/26
Chardan CapitalCHF6.60buy―Initiated10/20/26
Lucid CapitalCHF4.95→CHF11.56buy―Initiated09/08/26
H.C. WainwrightCHF7.43buy―Reiterated08/21/26
BarclaysCHF2.48sell―Reiterated08/20/26
BTIGCHF4.13buy―Reiterated08/19/26
Cantor Fitzgerald Analyst forecast on CH:TVRDUnknown AnalystNot RankedCantor Fitzgerald―hold―Reiterated08/19/26
Raymond JamesCHF8.25buy―Upgraded07/08/26
Piper SandlerCHF10.73buy―Upgraded07/08/26
OppenheimerCHF8.25buy―Reiterated05/11/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
DFTXDefinium Therapeutics
RDNTRadnet
AXGNAxoGen
PLSEPulse Biosciences
AHCOAdaptHealth

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tvardi Therapeutics

3 Months
Success Rate4/12 ratings generated profit
33%
Average Return
-16.03%

Copying Debanjana Chatterjee's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -16.03% per trade.

1 Year
Success Rate1/12 ratings generated profit
8%
Average Return
-67.57%

Copying Debanjana Chatterjee's trades and holding each position for 1 Year would result in 8.33% of your transactions generating a profit, with an average return of -67.57% per trade.

2 Years
Success Rate1/12 ratings generated profit
8%
Average Return
-69.80%

Copying Debanjana Chatterjee's trades and holding each position for 2 Years would result in 8.33% of your transactions generating a profit, with an average return of -69.80% per trade.

TVRD Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for TVRD
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy9111285
Buy00000
Hold11110
Sell35530
Strong Sell00000
total131718125

In the current month, TVRD has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TVRD average Analyst price target in the past 3 months is 6.74.

TVRD Financial Forecast

CHF-2CHF-1.5CHF-1CHF-0.5CHF0Q4 2025Q3 2026Q4 2026
HighCHF-0.11
ConsensusCHF-0.32
LowCHF-0.45

TVRD Earnings Forecast

Next quarter’s earnings estimate for TVRD is -CHF 0.32 with a range of -CHF 0.45 to -CHF 0.11. The previous quarter’s EPS was -CHF 0.40. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF-1CHF-0.5CHF0CHF0.5CHF1Q4 2025Q3 2026Q4 2026
HighCHF0.00
ConsensusCHF0.00
LowCHF0.00

TVRD Sales Forecast

Next quarter’s sales forecast for TVRD is CHF 0 with a range of CHF 0 to CHF 0. The previous quarter’s sales results were ―. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

TVRD Stock Forecast FAQ

What is CH:TVRD’s average 12-month price target, according to analysts?
Based on analyst ratings, Tvardi Therapeutics’s 12-month average price target is CHF6.74.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Tvardi Therapeutics a Buy, Sell or Hold?
Tvardi Therapeutics has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 1 hold ratings and 1 sell ratings.
What is Tvardi Therapeutics’s share price target?
The average share price target for Tvardi Therapeutics is CHF6.74. This is based on 7 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF11.56, and the lowest forecast is CHF2.48. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about Tvardi Therapeutics?
Tvardi Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Street analysts.
How can I buy shares of Tvardi Therapeutics?
To buy shares of CH:TVRD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.